Nippon Shinyaku Set To Launch Anti-Alcoholism Drug In Japan In May
This article was originally published in PharmAsia News
Executive Summary
Nippon Shinyaku expects to launch its Campral (acamprosate) anti-alcoholism drug at home on the Japanese market in May, the company said after receiving clearance from the health ministry.